scorecardresearch
Add as a preferred source on Google
Tuesday, November 25, 2025
TopicRemdesivir

Topic: Remdesivir

Remdesivir, favipiravir sales zoom to record Rs 1,000 crore in 7 months in Covid year

Indian pharma industry launched 44 new antiviral brands in 2020, against just 10 such launches in 2019. However, total number of new brands saw 40% decline.

Scientists identify Covid drug that’s ‘27.5 times more potent than remdesivir’

A peer-reviewed study in Science journal concluded that the drug plitidepsin had "potent preclinical efficacy" against SARS-CoV-2.

Cipla to experiment with Covid drug remdesivir composition to reduce effect on kidneys

Government's subject expert committee asks Cipla to assess renal toxicity of remdesivir's new formulation through a bioequivalence study as well as clinical trials.

Vaccines are great news, but that doesn’t mean we can ignore therapeutics

Even if vaccines are as effective in the real world as they look in clinical trials, they can’t change the course of the pandemic overnight. We need reinforcements.

India will make Covid vaccine accessible to ‘closest friends’, Shringla says in Nepal

Shringla was speaking after handing over 2,000 vials of anti-virus drug Remdesivir to Nepal's Foreign Minister Pradeep Kumar Gyawali to help it contain the Covid pandemic.

WHO advice on remdesivir is a warning for Covid-19 vaccines

The WHO’s thumbs-down on remdesivir highlights why the FDA has to do more than merely rubber-stamp Covid-19 treatments in the face of heavy White House pressure to move quickly.

Delhi doctors unlikely to follow new WHO advice, say remdesivir works in moderate Covid cases

WHO Friday advised against use of remdesivir for Covid because there’s ‘no evidence’ it improves survival, but doctors say it works on moderately ill patients.

WHO advises against use of remdesivir to treat hospitalised Covid patients

WHO experts say their findings shouldn’t be interpreted to mean remdesivir is ineffective, but that there is no evidence it improves patient-important outcomes.

Remdesivir needs more testing in Covid Solidarity trial before being junked — ICMR-NARI chief

ICMR-NARI is body responsible for conducting WHO Solidarity trial in India, and its director Panda says remdesivir cannot be ruled out as a Covid treatment yet.

Final results of US trial reveal remdesivir could shorten recovery time in Covid patients

The results, published in NEJM, come weeks after WHO's Solidarity Trial concluded that remdesivir had little to no effect on hospitalised Covid patients.

On Camera

Worker exploitation powers the firework industry in Tamil Nadu’s Sivakasi

For an industry globally classified as hazardous, protections such as health insurance and a provident fund for workers are necessities. In Sivakasi, they remain elusive.

172 countries & counting, India looks to hit new record in rice exports. But there’s a flip side

The industry forecasts exports are set to grow 16% in 2025-26, boosted by surplus domestic production and a drive to push into 26 underserved global markets with strong potential.

India and France to jointly manufacture HAMMER air-to-surface missile

Indigenisation level will progressively increase up to 60 percent with key sub-assemblies, electronics and mechanical parts being manufactured locally.

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.